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An anaphylactic shock is a time-critical emergency situation. The decision-making during emergencies is an important
responsibility but difficult to study. Eye-tracking technology allows us to identify visual patterns involved in the decision-making.
The aim of this pilot study was to evaluate two trainingmodels for the recognition and treatment of anaphylaxis by laypeople, based
on expert assessment and eye-tracking technology. A cross-sectional quasi-experimental simulation study was made to evaluate
the identification and treatment of anaphylaxis. 50 subjects were randomly assigned to four groups: three groups watching different
training videos with content supervised by sanitary personnel and one control group who received face-to-face training during
paediatric practice. To evaluate the learning, a simulation scenario represented by an anaphylaxis’ victim was designed. A device
capturing eye movement as well as expert valuation was used to evaluate the performance. The subjects that underwent paediatric
face-to-face training achieved better and faster recognition of the anaphylaxis. They also used the adrenaline injector with better
precision and less mistakes, and they needed a smaller number of visual fixations to recognise the anaphylaxis and to make the
decision to inject epinephrine. Analysing the different video formats, mixed results were obtained.Therefore, they should be tested
to evaluate their usability before implementation.
1. Introduction
An anaphylactic shock is a time-critical emergency situation.
The identification of the anaphylaxis depends on the recogni-
tion of its signs and symptoms. This reaction can occur from
minutes until hours after exposure to allergens [1].
The optimalmanagement of anaphylaxis requires an intra-
muscular epinephrine injection using an autoinjector [1, 2].
The intramuscular administration of epinephrine in the thigh
is widely recognised as the first line of medical treatment for
anaphylaxis. The administration must be carried out imme-
diately once a diagnosis of anaphylaxis is suspected [1–3].
It is estimated that anaphylaxis affects around 0,05–2%
of the population, being the most frequent incident among
children and adolescents [4]. Kids spent a great part of
their time at school; therefore, the training of teachers and
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n = 50 (26 ♂ 24 ♀)
IS: Kolmogorov-Smirnov, Chi Square statistic, and z-value.
AS and AT: mean, SD, and CI 95%. Shapiro-Wilk and test Friedman.
A signicance level of P < 0.05 was considered for all analyses.
Figure 1: Flowchart.
caregivers in first aid has been strengthened in later years [5–
7].
Another relevant aspect in time-critical emergency has
to do with decision-making. Decision-making in emergency
is an important responsibility but difficult to study since it
is an internal process that occurs rapidly [8]. Eye-tracking
technology has been widely used in the fields of marketing
and sports [9, 10] to recognise decision-making processes and
has recently been introduced into the clinical field [11].
Therefore, the aim of this pilot study was to evaluate
two training models (video versus face-to-face) for the
recognition and treatment of anaphylaxis by teachers, based
on expert assessment and eye-tracking technology.
2. Materials and Methods
2.1. Sample. A convenience sample consisting of 50 teacher
assistants from the Faculty of Education and Sport Sciences
of University of Vigo participated in this study. The sample
was formed by 26 men and 24 women, with an average age of
24 ± 7 years.
Their participation was voluntary and no one was
benefitted or disadvantaged by participating in the study.
Participants with previous training or experience of using
epinephrine autoinjector were excluded.
All participant signed written informed consent forms,
authorising the use of their data. After collection, all data
was anonymised. This study followed the ethical principles
of the Helsinki Declaration. The Spanish legislation does
require approval from an ethical committee for noninvasive
simulation studies.
2.2. Design. A controlled simulation study was made to
evaluate the identification of signs and symptoms of the
anaphylactic reaction and its emergency treatment. For this
a cross-sectional quasi-experimental study design was used
(Figure 1).
2.2.1. Training in Recognising and Treating Anaphylaxis. The
subjects were randomly allocated into four groups, to which
we assigned four different training methods. The content of
the training was about the recognition of anaphylaxis, as well
as its emergency treatment using an epinephrine injector.
Three of the groups received their training through videos
and the fourth received a face-to-face training by a paedia-
trician (PT) (see online Supplementary Video in Supplemen-
tary Material, available online at https://doi.org/10.1155/2017/
9837508). The training time never exceeded ten minutes.
2.2.2. Methodology of the Videos. Training 1 (T1) consisted
of a fictional videowith professional actors, scripted by paedi-
atricians (https://www.youtube.com/watch?v=v8qI6qL8sv0).
Training 2 (T2) was based on an instructional video made by
the Spanish association for peoplewith allergies (https://www
.youtube.com/watch?v=C9H2Adjkh7c). Training 3 (T3) con-
sisted of an amateur video with educational purpose re-
corded by paediatricians (https://www.youtube.com/watch?v=
8kEJSzGx4 4).
2.3. Variables and Evaluation System. To begin with, demo-
graphic data of sex and agewere recorded.Thereafter the vari-
ables to be used for the studywere collected: (A) identification
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Table 1: Variables of the study.
(A) Identification of symptoms (IS) (B) Autoinjector administration skills (AS) (C) Administration time (AT)
Signs and symptoms that indicate
presence of anaphylactic shock on
cutaneous (pruritus and morbilliform
rash) and respiratory (dyspnea and
cough) level.
Symptoms 1 (S1): number of visual
fixations towards the signs and symptoms
that the participant makes before using
the autoinjector.
Symptoms 2 (S2): number of visual
fixations towards the signs and symptoms
that the participant makes during the
administration of the autoinjector.
Symptoms 3 (S3): number of visual
fixations towards the signs and symptoms
that the participant makes after the
administration of the autoinjector.
Symptoms 1 in percentage (S1%):
percentage of visual fixations towards the
signs and symptoms that the participant
makes before using the autoinjector.
Symptoms 2 in percentage (S2%):
percentage of visual fixations towards the
signs and symptoms that the participant
makes during the administration of the
autoinjector.
Symptoms 3 in percentage (S3%):
percentage of visual fixations towards the
signs and symptoms that the participant
makes after the administration of the
autoinjector.
Autoinjector error (AE): incorrect or no use
of the injector. Incorrect use was considered
as using the injector upside down, no
removal of security cap, and/or no firing of
the needle during administration.
Thigh localization (TL): it was considered as
a quality localization if the administration
was made in the thigh musculature.
Quality administration (AQ): it was
considered as a quality administration if
(i) the injector was prepared and used in a
correct way,
(ii) the injection time (IT) was equal to or
greater than ten seconds,
(iii) the administration was made in the
thigh musculature.
Efficient administration (AE): an efficient
administration was recorded when, even
though a quality administration was not
performed, it was efficient for the patient. It
was considered as an efficient
administration when
(i) the injector was prepared and used in a
correct way,
(ii) the injection time (IT) was equal to or
greater than three seconds,
(iii) the administration was made in the
thigh musculature.
Hand time (HT): time (in seconds) from
the beginning of the scenario until the
participant held the injector in his or her
hand.
Use time (UT): time (in seconds) from
the beginning of the scenario until the
injection was made.
Injection time (IT): time (in seconds) that
the injector remained inserted in the
patient’s thigh to inject adrenaline.
of symptoms (IS), (B) autoinjector administration skills (AS),
and (C) administration time (AT); see Table 1.
To evaluate the IS, the eye movement was registered by
Mobile Eye from ASL Laboratory (Bedford, USA) (Figure 2).
It is composed of two cameras mounted on a pair of light
glasses. One to record the scene, and the other one uses the
reflection on a lens produced by the cornea and the pupil, to
capture were the participants focus their vision. Both signals
are registered through its DVCR recording unit and merged
by the computer system, producing a compound image of the
environment observed together with the participant’s visual
fixations. The Mobile Eye system was calibrated using the
Eye Vision 2.2.5 software, and the videos rendered during
the study were analysed using the ASL Result Plus Gaze
Map software. Both software packages were run on an ACER
ASPIRE 5920G. To evaluate the AS and AT, two expert
nurses with experience of out-of-hospital emergencies were
responsible for registering the variables using a checklist.
2.4. Simulation Scenario. The scenario was designed by
experts in simulations and emergencies. The case design was
based on clinical criteria for diagnosing anaphylaxis from the
World Allergy Organization Guidelines for the Assessment
and Management of Anaphylaxis [1]. To assure consistency
between the simulations, the case was programed so each
Figure 2: Eye movement analysis.
event happened in the same moment. Allowing identical
synchronisation between all session.
The participant, wearing the eye-tracking device, entered
the room were the anaphylactic shock simulation was taking
place. Before entering, they were asked tomake decisions and
act as if it was a real situation.
They encountered two collaborators in the room, each
sitting on a chair near a table. One of them, a 27-year-
old woman, represented the clinical criteria for diagnosing
anaphylaxis [1]: acute appearance of a disease with cuta-
neous affectation (itching, urticarial, and morbilliform rash)
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Figure 3: Cutaneous symptomatology.
and compromised respiratory function (cough, dyspnea,
increased respiratory rate, shortness of breath, and chest
tightness). For this purpose, the victim was wearing make-
up simulating the cutaneous symptomatology of exposure to
an allergen (Figure 3).
The allergen that triggered the anaphylactic shock
(roasted corn kernels), a telephone, and a women’s purse,
simulating the victim’s personal belongings were placed
on top of the table in front of the simulated victim. The
purse contained two epinephrine autoinjector trainers (Jext
Trainer, ALK-Abelló, Hoersholm, Denmark).
The goal for the participants was to identify the person
that was suffering an anaphylactic shock and—after calling
emergency services—find the epinephrine injector to make
the administration.
Two researchers oversaw the whole experiment from one
part of the room, evaluating the autoinjector administration
skills (AS) and the administration time (AT). None of
them gave any information to the participants during the
experiment.
The simulation finished when the participants adminis-
trated the adrenaline, when they stated that they had finished,
or if the participants had not performed any action in 100
seconds.
2.5. Statistical Analysis. Thestatistical analysis wasmadewith
SPSS version 20 for Macintosh (version 20.0, Chicago, IL,
USA).
For the variables identification of symptom (IS), the
normality distribution of the data was checked with the
Kolmogorov-Smirnov test completed by the Lilliefors
method. To test the homogeneity of distribution among
groups (T1, T2, T3, and PT) frequencies per nominal variable
were obtained by analysing the differences between the
observed and expected frequency, while using the Chi
Square statistic (𝜒2). We performed a post hoc analysis when
the Chi Square test turned out to be significant; this was
done in a similar way as proposed by Beasley & Schumacher
[12] using the corrected residuals (z-value). A level of −1.96
< z-value > 1.96 was considered significant. If the degrees
of freedom (df) are above 1 (in the opposite case the phi
coefficient would be used), the appropriate statistical index
to determine the size of the effect is Cramér’s 𝑉 (𝑉) [13].
For Chi Square analysis, the magnitude of the effect size was
measured by calculating Cramér’s 𝑉. According to Cramér
[14] if df = 3, 𝑉 = 0.06 to 0.17 describes a small effect,
𝑉 = 0.18 to 0.29 describes a medium effect, and 𝑉 ≥ 0.30
describes great effect. For each of the tests used in this
research the significance value stood at the 𝑃 < 0.05 level.
The variables of autoinjector administration skills (AS)
and administration time (AT) were described usingmeasures
of central tendency (mean) and of dispersion (standard
deviation and a 95% confidence interval). Normality was
tested using Shapiro-Wilk’s test. Friedman’s test was used to
compare the variables between groups. A significance level of
𝑃 < 0.05 was considered for all analyses.
3. Results
3.1. Identification of Symptom (IS). Significant differences for
the variables S1 and S3were found between the groups PT and
T3. No other significant results were found (Table 2).
The participants from the PT group made less visual
fixations towards the victim’s symptoms [S1 (8.7 ± 9.7), S2
(0.6 ± 1), and S3 (0.5 ± 1)], whereas the participants from the
T1 [S1 (36.3 ± 53.9), S2 (5.6 ± 9.9), and S3 (4.9 ± 11.5)] and T3
[S1 (34.7 ± 30), S2 (3.2 ± 7.4), and S3 (2.2 ± 3.2)] groups made
more visual fixations towards the symptoms.
3.2. Autoinjector Administration Skills (AS). The distribution
of nominal variables is presented in Table 3. Total distribution
by nominal variable reveals an unequal distribution for each
of the groups in autoinjector error (𝜒2 = 17.408, 𝑃 < 0.001,
𝑉 = 0.59), thigh localization (𝜒2 = 14.949, 𝑃 < 0.01,
𝑉 = 0.55), quality administration (𝜒2 = 8.269, 𝑃 < 0.05,
𝑉 = 0.25), and efficient administration (𝜒2 = 13.413,
𝑃 < 0.01, 𝑉 = 0.52). For the autoinjector error variable,
the 𝑧-values show that the PT (good: 𝑧-value = 3.5; bad:
𝑧-value = −3.5) and the T3 (good: 𝑧-value = 3.4; bad: 𝑧-
value = −3.4) are away from the average values. Regarding
the PT group, a higher probability of correct use of the
injector is seen (good: 𝑧-value = 3.5) and a lower probability
of correct use for the T3 group (bad: 𝑧-value = 3.4). For the
T1 group a lower probability of administering the injection
in the correct musculature is observed (bad 𝑧-value = 3.8).
Lastly, the PT group administered the medicine significantly
more efficiently than the other groups (good: 𝑧-value = 2.8),
with the T1 group having the lowest probability of correct
administration (bad: 𝑧-value = 2.2).
The T1 administered the epinephrine injection in the
wrong place most of the times (70%) in comparison with the
T2 and PT groups that administrated it in the correct place,
92,3% and 91,7%, respectively.
The T2 group made a quality administration in 38,5%
of the cases, compared to the PT group that made a quality
administration in 33,2% of the cases. Conversely, the efficient
administration was widely performed better by the PT group
(75%) in comparison with the T2 (53,8%), T3 (20%), and T1
(10%) group.
3.3. Administration Time (AT). The data of the administra-
tion time variables is presented in Table 4. The hand time is
significantly different comparing T1 to T3 (𝑃 = 0.034) as well






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































8 BioMed Research International
as PT to T3 (𝑃 = 0.035). There is also a significant difference
in use time between T1 and PT (𝑃 = 0.034) as well as between
PT and T3 (𝑃 = 0.011). The injection time did not differ
significantly between any groups.
The PT group had the best results in the administration
time variables. They were the second fastest group to grab
the epinephrine autoinjector (HT), fastest one to perform
the injection (UT; 36 ± 21.5), and fastest one to prepare
the autoinjector for administration. Once the injection was
initiated, the PT group let the injector remain inserted for
8.7 ± 4.8 seconds.
4. Discussion
Anaphylaxis is an emergency in which a rapid intervention is
critical. Recognising an anaphylactic shock can be complex.
In our study, participants with very basic training showed
differences in the ability to recognise and treat anaphylaxis.
Different video training has shown success in teaching
techniques related to the emergencies [15, 16].
In our study, traditional face-to-face training provided by
expert personnel showed better results than video training,
contrary to various studies that have shown better effect using
video training in teaching CPR [15, 16].
The participants of the PT group recognised the symp-
toms of anaphylaxis faster andwith fewer visual fixations.The
participants of this group (PT) were the second fastest to grab
the injector (hand time = 27.5 ± 18.5 seconds) and fastest in
administering the epinephrine. They performed the correct
treatment in 36±21.5 seconds from the start of the simulation.
Johnston et al. [17] found in their study that the average
time for anaesthesia residents to diagnose anaphylaxis in an
operating room simulationwas 7.6±2.4minutes, and the time
to administer the epinephrine was 6.5±2.1minutes. A greater
emphasis needs to be put on the correct and early recognition
and treatment of anaphylaxis by healthcare professionals [18].
The manufacturers’ recommendation for correct admin-
istration of epinephrine is to retain the autoinjector in place
for ten seconds from the moment of puncture [19, 20]. The
participants in our study maintained the injector during
4.6 ± 3.9 (T1), 7 ± 4.9 (T2), 6.8 ± 4.3 (T3), and 8.7 ± 4.8
(PT) seconds.The PT group was closest to the recommended
time. The variability existing between different injectors [21,
22] in the rate of drug administration led us to include
efficacy of administration, using a second administration
time. The injector used in our study delivers more than
70% of the epinephrine in three seconds [21]; therefore we
considered it as efficient if the administration time exceeded
this limit. The World Allergy Organization Guidelines for
the Assessment and Management of Anaphylaxis [1] do not
mention the adequate time that the epinephrine injector
should be maintained inserted.
The study by Arga et al. [23] in which they assessed the
ability of physicians to use epinephrine injectors before and
after receiving theoretical and practical training showed that
errors in the use of the injectors may be related to their
designs. In our study, incorrect use of the autoinjector was
more frequent in the groups receiving video training (T1:
93.5%; T2: 46.2%; and T3: 80%) than in the group receiving
face-to-face training, in which no one committed any errors
during the use of the autoinjector. Considering our results,
usage errors of the autoinjector seem more related to the
received training than to the design of the injector. In the
study by Grouhi et al. [24] which evaluated the abilities of
physicians, nurses, and pharmacists to use the epinephrine
autoinjectors, 75%of the participants did not demonstrate the
ability to use the device properly. In our study the percentage
varied from 100% (T1) incorrect use, to 93.5% (T3), 66.7%
(PT), and 61.5% (T2), respectively.
Participants receiving face-to-face training are more
likely to perform an effective administration. These partic-
ipants made fewer visual fixations towards the symptoms
before, during, and after the administration than the rest of
the groups. This could be because, due to their training, they
recognise the signs of the anaphylaxis faster and therefore
do not need as many visual fixations. In contrast, the T1
and T3 groups made a higher number of visual fixations
before, during, and after (S1, S2, and S3) the administration
and therefore performed it worse than the T2 and PT.
Understanding the decision-making process in emergency
situations can optimize the training of and recommendations
for first responders. In this sense, eye-tracking technology
allows us to identify the visual variables involved in the
decision-making process [9, 10].
To our knowledge, no study of anaphylaxis treatment
performance using eye-tracking and expert assessment has
been made. We have found that training by a healthcare
expert increases the likelihood of proper use and rapid and
efficient administration of epinephrine autoinjector. Future
researches should be focused on the use of the eye-tracking
in other different scenarios. Brockow et al. showed that
a standardized 6-h educational intervention improves the
knowledge and practical emergency management skills just
after the training and after 3 months [7]. Differences between
a brief and a standardized training could contribute to
structuring better programs, methodology, and contents of
anaphylaxis training courses.
5. Limitations
As well as other simulation studies, the results should be
interpreted with caution in the case of real victims.
The results should not be generalized due to the existing
variability in the autoinjectors.
The efficacy of an administration will depend on the type
of injector and its characteristics (epinephrine injection rate,
puncture depth, and needle length).
6. Conclusions
Face-to-face training by a paediatrician improves the ability
to recognise anaphylaxis and the probability of correct use of
injector. Training videos can be a useful resource but has a
great variability in its efficacy.
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métodos audiovisuales en escolares,” Emergencias, vol. 28, no. 2,
pp. 103–108, 2016.
[17] E. B. Johnston, C. King, P. A. Sloane et al., “Pediatric anaphylaxis
in the operating room for anesthesia residents: a simulation
study,” Pediatric Anesthesia, vol. 27, no. 2, pp. 205–210, 2017.
[18] F. E. R. Simons, M. Ebisawa, M. Sanchez-Borges et al., “2015
update of the evidence base: World Allergy Organization
anaphylaxis guidelines,” World Allergy Organization Journal,
vol. 8, no. 1, article 32, 2015.
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